MedCan Summit Speaker

Carmen Doran

Chief Executive Officer,
Helius Therapeutics

Helius Therapeutics is vertically-integrated and has a bold vision, to become a world leader in the research, development and marketing of next-generation medical cannabis products. 

Carmen Doran, CEO, has a strong international background in pharmaceutical operations including site and global roles in both human and animal health. Carmen holds a Masters’ Degree in Biomedical Engineering from the University of Canterbury.


All Sessions by Carmen Doran

Day 1 - Industry Summit - 10 February

Time Industry Stream Science Stream
10:05
  • Comparing New Zealand’s medicinal cannabis industry to the world
  • The opportunity to join the global industry and be amongst the global players
  • What is unique about New Zealand’s harvest (and product) to drive a global opportunity to drive our economy as well as contribute to global healthcare and wellbeing outcomes?
  • What are the milestones that the industry needs to reach to achieve a commercially sustainable industry?
  • Keeping it local – what are the collaboration options for Maori businesses and organisations to expand their interest in primary industries?

Manu Caddie, Co-Founder, Kaihautu – Innovation and Regulation, Rua Bioscience

Carmen Doran 
Chief Executive Officer, Helius Therapeutics
Mark Lucas 
Chief Executive Officer, Cannasouth
Tim Aldridge 
Managing Director, Puro
Mitch Cuevas 
Pharmaceutical Director, Eqalis
  • Comparing New Zealand’s medicinal cannabis industry to the world
  • The opportunity to join the global industry and be amongst the global players
  • What is unique about New Zealand’s harvest (and product) to drive a global opportunity to drive our economy as well as contribute to global healthcare and wellbeing outcomes?
  • What are the milestones that the industry needs to reach to achieve a commercially sustainable industry?
  • Keeping it local – what are the collaboration options for Maori businesses and organisations to expand their interest in primary industries?

Manu Caddie, Co-Founder, Kaihautu – Innovation and Regulation, Rua Bioscience

Carmen Doran 
Chief Executive Officer, Helius Therapeutics
Mark Lucas 
Chief Executive Officer, Cannasouth
Tim Aldridge 
Managing Director, Puro
Mitch Cuevas 
Pharmaceutical Director, Eqalis
11:20
Industry
Carmen Doran 
Chief Executive Officer, Helius Therapeutics
Eva Neshat 
Founder and Chief Executive Officer, Elysian Pharmaceuticals & CannaPlus+
Zoë Reece 
Founder and CEO, Ora Pharm
Dr Dottie Clower 
Chief Scientific Officer, Puro
12:20
Science
Carmen Doran 
Chief Executive Officer, Helius Therapeutics
Ali Seyfoddin 
Associate Professor of Drug Delivery and Biological Engineering Deputy Head of School, School of Science, Auckland University of Technology

More Speakers

Martin A Lee

Director

Zoë Reece

Founder and CEO

Brooke van Velden

List Member

Kristen Lunman

Co-Founder and GM